Results 121 to 130 of about 44,049 (225)

What Is Your Diagnosis? Multiple Subcutaneous Lumps in a Horse

Veterinary Clinical Pathology, EarlyView.
Federica Meistro, Maria Virginia Ralletti, Riccardo Rinnovati, Alessandro Spadari, Maria Morini   +4 more
wiley   +1 more source

Host Transcriptomics and Culture‐Independent Testing for the Management of Febrile Neutropenia: Data From an Observational Study Conducted in a Bone Marrow Transplant Unit

European Journal of Haematology, Volume 116, Issue 5, Page 625-634, May 2026.
ABSTRACT Background Managing febrile neutropenia is challenging due to the limited sensitivity of blood culture (BC) and the lack of tools differentiating infectious from non‐infectious fever. T2 magnetic resonance (T2MR) is a culture‐independent system detecting bacteria (T2Bacteria) and yeasts (T2Candida); SeptiCyte RAPID is a host response assay ...
Anna Maria Peri, Andrea S. Henden, Ricky Nelles, Mark D. Chatfield, Patrick N. A. Harris, Glen Kennedy, David L. Paterson   +6 more
wiley   +1 more source

New Perspectives of Interferon-alpha2 and Inflammation in Treating Philadelphia-negative Chronic Myeloproliferative Neoplasms

HemaSphere, 2021
Hans C. Hasselbalch, Richard T. Silver
doaj   +1 more source

Associació de l'estat mutacional de JAK2 i les anomalies citogenètiques en les neoplàsies mieloproliferatives cròniques Filadèlfia negatives : Correlació amb les dades clíniques i analítiques [PDF]

, 2013
L'estudi correlaciona l'estat mutacional de JAK2V617F amb les alteracions citogenètiques, algunes dades clíniques i paràmetres de laboratori i valorar l'impacte sobre la progressió i pronòstic de la malaltia de 526 casos de NMPc Ph-.
Feliu Frasnedo, Evarist, Millá Santos, Fuensanta, Universitat Autònoma de Barcelona. Departament de Medicina, Universitat Autònoma de Barcelona. Facultat de Medicina, Xandri Puig, Marisol   +4 more
core  

MESENCHYMAL STEM CELLS IN PH-NEGATIVE MYELOPROLIFERATIVE NEOPLASMS: IDLE OBSERVERS OR PART OF THE DISEASE? [PDF]

, 2019
Accurso, V., Cordova, A., Di Piazza, F., Di Stefano, A. B., Lo Re, J., Mancuso, S., Russo, A., Santoro, M., Siragusa, S.   +8 more
core   +1 more source

Combination therapy with interferon and ruxolitinib for polycythemia vera and myelofibrosis: are two drugs better than one?

Haematologica, 2020
Richard T. Silver
doaj   +1 more source

Evaluation of the association between the JAK2 46/1 haplotype and chronic myeloproliferative neoplasms in a Brazilian population

Clinics, 2013
OBJECTIVE: The JAK2 46/1 haplotype has recently been described as a major contributing factor to the development of myeloproliferative neoplasm, whether positive or negative forthe JAK2 V617F mutation.
Sarah Pagliarini-e-Silva, Bruna Cunha Santos, Elizangela Mendes de Figueiredo Pereira, Mari Ellen Ferreira, Elaine Cristina Baraldi, Ana Maria Sell, Jeane Eliete Laguila Visentainer   +6 more
doaj  

Evaluation of bone marrow morphology is essential for assessing disease status in recombinant interferon α-treated polycythemia vera patients

Haematologica, 2017
Elizabeth Margolskee, Spencer Krichevsky, Attilio Orazi, Richard T. Silver   +3 more
doaj   +1 more source

An agenda for future research projects in polycythemia vera and essential thrombocythemia

Haematologica, 2020
Tiziano Barbui, Alessandro Maria Vannucchi, Paola Guglielmelli, Valerio De Stefano, Alessandro Rambaldi   +4 more
doaj   +1 more source

Are Myeloproliferative Neoplasms-Unclassifiable Really Unclassifiable? [PDF]

EJHaem
Barosi G, Rosti V, Gale RP.
europepmc   +1 more source